Connect Biopharma Holdings Limited Accounts Payable
Connect Biopharma Holdings Limited (CNTB) had Accounts Payable of $2.02 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $2.02M.
- 2026-03-31: Accounts Payable, Current $4.31M.
- 2025-12-31: Accounts Payable, Current $1.96M.
- 2025-09-30: Accounts Payable, Current $1.99M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $2.02M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $4.31M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $1.96M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $1.99M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.29M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $817.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $342.00K 10-K · filed 2026-03-31 |
| 2023-12-31 | $2.21M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |